Hydroxyprogesterone Caproate recall: Sterility Concern
Hydroxyprogesterone Caproate (BUD) 350mg/ml , 4 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA…
Why was Hydroxyprogesterone Caproate recalled?
Lack of Assurance of Sterility
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 02212020@2, Expires after 04-21-2020; Lot #: 02262020@52 Expires after 04-26-2020
- Product
- Hydroxyprogesterone Caproate (BUD) 350mg/ml , 4 mL, Injectable, Rx only, INNOVATIVE COMPOUNDING PHARMACY, 41536 EASTMAN DRIVE SUITE A MURRIETA , CA…
- Recalling firm
- Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy
- Quantity
- N/A
- Distribution
- Patient Distribution list includes addresses in the following states: CA, ME, TX
- Recall date
- April 15, 2020
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)